Trental: Restore Healthy Blood Flow for Improved Mobility
Trental
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | 0.96 $ | 57.33 $ (0%) | 🛒 Add to cart |
| 90 | 0.83 $ | 86.00 $ 74.88 $ (13%) | 🛒 Add to cart |
| 120 | 0.77 $ | 114.66 $ 92.43 $ (19%) | 🛒 Add to cart |
| 180 | 0.70 $ | 171.99 $ 125.19 $ (27%) | 🛒 Add to cart |
| 270 | 0.66 $ | 257.99 $ 179.01 $ (31%) | 🛒 Add to cart |
| 360 | 0.64 $
Best per pill | 343.98 $ 229.32 $ (33%) | 🛒 Add to cart |
Synonyms
| |||
Trental (pentoxifylline) is a prescription medication specifically formulated to improve blood flow by reducing the viscosity of blood. It is primarily indicated for the symptomatic treatment of intermittent claudication, a condition caused by reduced arterial blood flow in the limbs. By enhancing microcirculation and oxygen delivery to tissues, Trental helps alleviate pain, cramping, and fatigue in the legs during physical activity, thereby increasing walking distance and overall functional capacity. This hemorheological agent works through multiple mechanisms to support vascular health and patient quality of life.
Features
- Active ingredient: Pentoxifylline 400 mg (in extended-release tablets)
- Pharmacological class: Hemorheological agent, xanthine derivative
- Mechanism of action: Reduces blood viscosity, improves erythrocyte flexibility, decreases platelet aggregation, and modestly reduces fibrinogen levels
- Formulation: Film-coated, extended-release tablets for twice-daily dosing
- Prescription status: Rx-only medication requiring medical supervision
Benefits
- Significantly increases pain-free and maximum walking distance in patients with intermittent claudication
- Improves microcirculatory blood flow and tissue oxygenation in affected limbs
- Reduces symptoms of cramping, pain, and fatigue during physical activity
- Enhances overall functional capacity and quality of life
- Provides well-tolerated symptomatic management with established safety profile
- Offers convenient twice-daily dosing regimen for patient compliance
Common use
Trental is primarily prescribed for the symptomatic management of intermittent claudication, a manifestation of peripheral arterial disease (PAD). This condition is characterized by reduced blood flow to the limbs, particularly the legs, resulting in pain, cramping, and fatigue during walking or exercise that typically resolves with rest. The medication is used as part of a comprehensive treatment approach that includes lifestyle modifications such as smoking cessation, exercise training, and management of other cardiovascular risk factors. While Trental provides symptomatic relief, it does not cure the underlying arterial disease and is not indicated for other forms of vascular insufficiency.
Dosage and direction
The recommended adult dosage of Trental is one 400 mg tablet taken three times daily with meals. Tablets should be swallowed whole and not crushed, chewed, or divided, as this may alter the extended-release properties. Dosage adjustments may be necessary for patients with renal impairment, particularly those with creatinine clearance below 30 mL/min, where a reduced dosage of one 400 mg tablet twice daily is recommended. Treatment response may not be immediate, and several weeks of therapy may be required before clinical benefits become apparent. Therapy should be continued indefinitely unless otherwise directed by a healthcare provider.
Precautions
Patients should undergo thorough medical evaluation before initiating Trental therapy to establish the diagnosis of intermittent claudication and rule out other potential causes of symptoms. Regular monitoring of blood pressure is recommended, particularly during initial therapy, as pentoxifylline can cause hypotension. Caution is advised in patients with recent surgical procedures, peptic ulcer disease, or those taking anticoagulant medications due to increased bleeding risk. Patients should be advised that Trental may cause dizziness or drowsiness and should exercise caution when operating machinery or driving until they know how the medication affects them. Regular follow-up with a healthcare provider is essential to monitor therapeutic response and potential adverse effects.
Contraindications
Trental is contraindicated in patients with known hypersensitivity to pentoxifylline, other xanthine derivatives such as caffeine, theophylline, or any component of the formulation. It should not be used in patients with recent cerebral or retinal hemorrhage. The medication is contraindicated in patients with severe cardiac arrhythmias, acute myocardial infarction, or severe coronary artery disease where the potential risks outweigh possible benefits. Trental is not recommended for use in children under 18 years of age due to insufficient safety and efficacy data in this population.
Possible side effects
The most commonly reported adverse reactions involve the gastrointestinal system and central nervous system. Gastrointestinal effects may include nausea (up to 30% of patients), vomiting, diarrhea, dyspepsia, bloating, and abdominal discomfort. Central nervous system effects may include dizziness (up to 20%), headache, anxiety, insomnia, and blurred vision. Cardiovascular effects such as chest pain, arrhythmias, hypotension, and flushing have been reported less frequently. Allergic reactions including rash, pruritus, and angioedema may occur in some patients. These side effects are typically mild to moderate in severity and often diminish with continued therapy.
Drug interaction
Trental may potentiate the effects of antihypertensive medications, requiring blood pressure monitoring and possible dosage adjustment. Concurrent use with anticoagulants such as warfarin may increase the risk of bleeding, necessitating close monitoring of coagulation parameters. Theophylline and other xanthine derivatives may increase the risk of adverse effects when administered with Trental. Medications that affect platelet aggregation, including NSAIDs and antiplatelet agents, may enhance the bleeding risk when combined with pentoxifylline. CYP1A2 inhibitors such as fluvoxamine may increase pentoxifylline concentrations, while inducers may decrease its efficacy.
Missed dose
If a dose of Trental is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one. Maintaining a consistent dosing schedule with meals is important for optimal therapeutic effect. If multiple doses are missed, patients should contact their healthcare provider for guidance on resuming therapy.
Overdose
Symptoms of Trental overdose may include severe hypotension, tachycardia, convulsions, somnolence, loss of consciousness, fever, and agitation. Management of overdose should include supportive measures with careful monitoring of vital signs and cardiac function. Gastric lavage may be considered if performed soon after ingestion. Activated charcoal may be administered to reduce absorption. There is no specific antidote for pentoxifylline overdose, and treatment should focus on symptomatic and supportive care. Hemodialysis may be of limited value due to pentoxifylline’s high protein binding and extensive tissue distribution.
Storage
Trental tablets should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept in its original container with the lid tightly closed to protect from moisture and light. Tablets should not be stored in bathrooms or other areas with high humidity. Keep out of reach of children and pets. Properly discard any expired or unused medication according to local regulations, typically through medication take-back programs or by mixing with undesirable substances before disposal in household trash.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Trental is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to therapy may vary, and the benefits and risks should be carefully considered before initiating treatment. Patients should not discontinue or modify their dosage without consulting their healthcare provider. The complete prescribing information should be consulted for comprehensive details about the medication, including full safety information and potential adverse reactions.
Reviews
Clinical studies have demonstrated that Trental provides statistically significant improvement in pain-free walking distance compared to placebo in patients with intermittent claudication. Many patients report meaningful symptomatic relief and improved quality of life after several weeks of consistent therapy. Healthcare providers note that while the effect is modest compared to exercise training and risk factor modification, Trental represents a valuable adjunctive therapy for appropriate patients. The medication is generally well-tolerated, with most adverse effects being mild and transient. Patient satisfaction surveys indicate that the convenience of twice-daily dosing contributes to good adherence rates among those who experience clinical benefit.